Plaintiffs Fight to Stop Transfer of Invokana Cases to NJ

, New Jersey Law Journal

   | 0 Comments

More than 100 plaintiffs with cases pending in Pennsylvania federal court over claims that the diabetes drug Invokana caused kidney damage are challenging the drugmaker's efforts to move those cases into a recently-established multidistrict litigation in New Jersey.

This premium content is reserved for New Jersey Law Journal subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202776601712

Thank you!

This article's comments will be reviewed.